Similar articles

• Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection.

  Bekker V, Scherpbier H, Pajkrt D, Jurriaans S, Zaaijer H, Kuijpers TW. Bekker V, et al. Pediatrics. 2006 Aug;118(2):e315-22. doi: 10.1542/peds.2005-2616. Epub 2006 Jul 17. Pediatrics. 2006. PMID: 16847077
• Human immunodeficiency virus type 1 quasi species that rebound after discontinuation of highly active antiretroviral therapy are similar to the viral quasi species present before initiation of therapy.

  Imamichi H, Crandall KA, Natarajan V, Jiang MK, Dewar RL, Berg S, Gaddam A, Bosche M, Metcalf JA, Davey RT Jr, Lane HC. Imamichi H, et al. J Infect Dis. 2001 Jan 1;183(1):36-50. doi: 10.1086/317641. Epub 2000 Dec 8. J Infect Dis. 2001. PMID: 11106537
• Three-class-resistant human immunodeficiency virus type 1 variant in a drug-naive heterosexual couple.

  Razzolini F, Saladini F, Malincarne L, Vicenti I, Palladino N, Romano L, Francisci D, Zazzi M. Razzolini F, et al. J Clin Microbiol. 2008 Nov;46(11):3856-9. doi: 10.1128/JCM.01122-08. Epub 2008 Sep 24. J Clin Microbiol. 2008. PMID: 18845824 Free PMC article.
• HIV-1 load quantitation: a 17-year perspective.

  Holodniy M. Holodniy M. J Infect Dis. 2006 Sep 15;194 Suppl 1:S38-44. doi: 10.1086/505352. J Infect Dis. 2006. PMID: 16921471 Review.
• [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].

  Panel de expertos de Gesida y Plan Nacional sobre el Sida. Panel de expertos de Gesida y Plan Nacional sobre el Sida. Enferm Infecc Microbiol Clin. 2009 Apr;27(4):222-35. doi: 10.1016/j.eimc.2008.11.002. Epub 2009 Feb 26. Enferm Infecc Microbiol Clin. 2009. PMID: 19246124 Spanish.